What is Exosomes

Exosomes are nano-sized vesicles, typically 30–150 nm in diameter, released by cells into the extracellular environment. They carry proteins, lipids, and nucleic acids (e.g., DNA, mRNA, and microRNA) between cells to regulate intercellular communication. Exosomes are more than just passive delivery vehicles. While they do transport biomolecules from one cell to another, they also actively influence the behavior of recipient cells—modulating immune responses, promoting tissue repair, altering the tumor microenvironment, and more. This is why exosomes are continuously studied for their wide-ranging therapeutic, health and beauty potential.
At REVIVEBIO, we focus on novel exosomes derived from Next-Generation Probiotics (NGPs)—our “Golden Exosomes”—for use in skincare and wellness applications, representing a new frontier in precision microbiome therapy.

Below are some of the most well-recognized exosome categories in the market

Category	Description	Pros	Cons
Eukaryotic Exosomes	Nanosized vesicles (30–150 nm) secreted by eukaryotic cells (e.g., immune, stem, tumor cells) via multivesicular bodies. Contain proteins (e.g., CD63, CD81), lipids, and RNAs, facilitating cell-to-cell communication across physiological and pathological processes. Found in biofluids like blood, urine, and saliva.	– Broad applicability in diagnostics and therapeutics – Well-characterized protein markers (e.g., CD63, CD9) – High biocompatibility for human applications	– Heterogeneous composition complicates purification – Low yield from cell cultures – High isolation costs – Can be animal-derived (e.g., pig), raising ethical, cultural, and immunogenicity concerns
Milk-Derived Exosomes	Exosomes isolated from milk (e.g., bovine, human, camel, yak) with a phospholipid bilayer, containing miRNAs, proteins, and lipids. Promote intestinal health, immune regulation, and tissue development, particularly in infants. Used in oral drug delivery and skincare.	– Abundant, scalable source (billions per liter of milk) – GRAS-certified for safety – Stable in gastrointestinal tract due to protective bilayer	– Complex milk composition (casein, fat globules) complicates isolation – Batch variability due to milk processing – Potential allergenicity in sensitive populations
Plant-Derived Exosomes	Exosome-like nanovesicles (50–1000 nm) from edible plants (e.g., ginger, lemon, grape). Contain plant-specific RNAs, lipids, and metabolites, offering anti-inflammatory, antioxidant, and antimicrobial effects. Used in nanomedicine and dietary therapies.	– High yield, low-cost production – Biocompatible and biodegradable – Broad therapeutic potential (e.g., anti-tumor, gut health)	– Lack specific protein markers like CD63 – Variable composition due to plant source variability – Limited human cell compatibility
Probiotic-Derived Exosomes	Extracellular vesicles from probiotic bacteria, containing microbial RNAs and proteins. Modulate gut microbiota, enhance immunity, and combat infections (e.g., C. difficile). Often studied in probiotic-dependent therapies.	– Enhance gut health and immunity – Probiotic-dependent antimicrobial effects – Potential for oral delivery	– Limited research on isolation and characterization – Low yield from bacterial cultures – Regulatory challenges for clinical use